மருத்துவ மையம் ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

$940K federal grant will fund MaineHealth research into COVID testing

$940K federal grant will fund MaineHealth research into COVID testing
mainebiz.biz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mainebiz.biz Daily Mail and Mail on Sunday newspapers.

United statesMaine medical centerElizabeth jacobsAngus kingMark swannKathleen fairfieldMaine medical center research instituteNational institutes of healthGreater portland healthPortland public health divisionNational institutesAmerican rescue planMedical center research institutePreble streetStreet executive director mark swannPublic health division

SynDevRx Announces Research Collaboration with Maine Medical Center Research Institute to Study the Effects of SDX-7320 In Obesity-Accelerated Multiple Myeloma Models

SynDevRx Announces Research Collaboration with Maine Medical Center Research Institute to Study the Effects of SDX-7320 In Obesity-Accelerated Multiple Myeloma Models
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesPeter corneliusMichaela reaganJames shanahanMaine medical center research institute michaela reaganMaine medical center research instituteSyndevrx incMaine medical centerTranslational researchMedical centerChief business officer jamesMedical center research instituteஒன்றுபட்டது கிஂக்டம்ஒன்றுபட்டது மாநிலங்களில்பீட்டர் கார்னெலியஸ்

Kojin Therapeutics Debuts to Solve Difficult Diseases Through Cell Behavior

Published: Jun 09, 2021 By Mark Terry Kojin Therapeutics launched with a $60 million Series A to initially focus on oncology and cell state biology. The round was led by Polaris Partners, Newpath Partners, and Cathay Health, affiliated to Cathay Capital. Participants included Leaps by Bayer, AbbVie, Eventide Asset Management, Alexandria, the Dana-Farber Cancer Institute’s Binney Street Capital, and several family offices. The approach came out of the laboratoryof Stuart Schreiber, Harvard University professor and co-founder of the Broad Institute. Co-founders of Kojin include Benjamin Cravatt, Stephanie Dougan and Vasanthi Viswanathan. The company’s technology is ferroptosis-based drug discovery, which is to say, iron-dependent cell death. Kojin says that difficult-to-treat diseases, which includes drug-resistant cancers, involve diseased cells that are sensitive to ferroptosis.

United statesAl iskandariyahHarvard universityDana farber cancer instituteJurgen eckhardtAmir nashatBenjamin cravattStephanie douganJoel barrishSteve davidsenNagesh mahanthappaSusan langerVasanthi viswanathanNortonb gilulaStuart schreiberKay ahn

Communicating Scientific Uncertainty About the COVID-19 Pandemic: Online Experimental Study of an Uncertainty-Normalizing Strategy

Han, Scharnetzki, Lary, Waterston); University of Iowa Carver College of Medicine ( Scherer); University of Utah ( Fagerlin); Oregon Health and Science University ( Dieckmann) .a strategy aimed at normalizing uncertainty as an expected state of affairs was effective in reducing at least some aversive psychological responses to the communication of uncertainty, whereas widely used alternative strategies aimed at promoting hope and prosocial values had no such effect. Expert guidelines on crisis communication stress the importance of acknowledging uncertainty - a defining feature of public health crises such as COVID-19 - in order to foster public accountability and trust. However, the communication of scientific uncertainty has the potential to promote negative cognitive, emotional, and behavioural responses, such as heightened risk perceptions, emotional distress, and decision avoidance. This study evaluates whether a communication strategy emphasising that uncertainty is exp

United statesSalt lake cityPaul kj hanAlistair thorpeLeob waterstonChristine laryElizabeth scharnetzkiAaronm schererAngela fagerlinNathanf dieckmannMaine medical center research institute hanSalt lake city va centerUniversity of utah thorpeScience university dieckmannOregon healthMedical center research institute

Jumping genes can prevent blood cancers: Study

Jumping genes can prevent blood cancers: Study By IANS | 4 Views Gallbladder, biliary tract cancer cases up 76% in 3 decades. Image Source: IANS News New York, April 9 : US scientists have found that transposons, also known as jumping genes, can protect against certain blood cancers and help develop new therapeutic targets. Transposons are DNA sequences that can move, or jump, from one location in the genome to another when activated. These jumping genes are a source of genetic mutations responsible for a number of human diseases. The findings, published in the journal Nature Genetics, can help predict how patients will respond to cancer therapies and find new therapeutic targets for acute myeloid leukemia (AML) the deadliest type of blood cancer in adults and children.

New yorkUnited statesJian xuChildren medical center research instituteUniversity of texas southwesternNature geneticsMedical center research instituteTexas southwesternAssociate professorபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்ஜியான் ஐயூகுழந்தைகள் மருத்துவ மையம் ஆராய்ச்சி நிறுவனம்பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் தென்மேற்குஇயற்கை ஜெநெடிக்ஸ்மருத்துவ மையம் ஆராய்ச்சி நிறுவனம்